Fulminant hepatitis B virus (HBV) infection in an infant following mother-to-child transmission of an e-minus HBV mutant: Time to relook at HBV prophylaxis in South African infants.
暂无分享,去创建一个
B. Eley | D. Hardie | S. Korsman | H. Smuts | O. Ogunbusi | R. D. De Lacy
[1] Jianguo Wu,et al. Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action , 2017, Scientific Reports.
[2] H. Smuts,et al. Hepatitis B Virus Genotype G: First Report of Complete Genomic Analysis from the African Continent , 2017 .
[3] Hepatitis B vaccines: WHO position paper – July 2017. , 2017, Releve epidemiologique hebdomadaire.
[4] Yongfang Jiang,et al. Molecular mechanisms of HBeAg in persistent HBV infection , 2016, Hepatology International.
[5] R. Pattinson,et al. Antenatal screening for hepatitis B virus in HIV-infected and uninfected pregnant women in the Tshwane district of South Africa. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[6] M. Cotton,et al. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. , 2015, Vaccine.
[7] R. Mohamed,et al. Universal Primers for Detection and Sequencing of Hepatitis B Virus Genomes across Genotypes A to G , 2015, Journal of Clinical Microbiology.
[8] H. Hsu,et al. Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes , 2014, PloS one.
[9] R. Parboosing,et al. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[10] R. Chaisson,et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa , 2014, Journal of the International AIDS Society.
[11] R. Tedder,et al. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa☆ , 2013, Vaccine.
[12] A. Kramvis,et al. Genotyping and Molecular Characterization of Hepatitis B Virus from Human Immunodeficiency Virus-Infected Individuals in Southern Africa , 2012, PloS one.
[13] H. Hsu,et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. , 2012, Gastroenterology.
[14] H. Zhuang,et al. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. , 2010, Antiviral research.
[15] Y. Wen,et al. Biological features of hepatitis B virus isolates from patients based on full‐length genomic analysis , 2009, Reviews in medical virology.
[16] M. Kew,et al. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[17] Mimi C. Yu,et al. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu‐speaking sub‐saharan Africans , 2005, Journal of medical virology.
[18] H. Coovadia,et al. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. , 2003, Archives of pediatrics & adolescent medicine.
[19] P. Venter,et al. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. , 2001, Vaccine.
[20] A. Zuckerman,et al. Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.
[21] H. Coovadia,et al. The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa. , 1988, International journal of epidemiology.
[22] A. Dibisceglie,et al. Prevalence of hepatitis B virus infection among black children in Soweto. , 1986, British medical journal.
[23] G. Dusheiko,et al. HEPATITIS B VIRUS CARRIER STATE IN BLACK CHILDREN IN OVAMBOLAND: ROLE OF PERINATAL AND HORIZONTAL INFECTION , 1984, The Lancet.